Bayer Schering Pharma to Set Up R&D Center in China

Bayer Schering Pharma, a Bayer subsidiary, says it will invest €100 million during the next five years to establish a global R&D center at Beijing. China will be the third country to host such a center for the subsidiary; the others are Germany and the U.S. Fibig: Increasing presence in Asia/Pacific. “We are continuously increasing our presence in the Asia/Pacific region where China is our key growth driver,” says Andreas Fibig, chairman of Bayer Schering Pharma’s board of management. “Beijing will be an important site for...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers